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Abstract
 .The pleckstrin homology domains PH domains derived from four different proteins, the N-terminal part of pleckstrin,
RAC-protein kinase, diacylglycerol kinase and the 130 kDa protein originally cloned as an inositol 1,4,5-trisphosphate
binding protein, were analysed for binding of inositol phosphates and derivatives of inositol lipids. The PH domain from
pleckstrin bound inositol phosphates according to a number of phosphates on the inositol ring, i.e. more phosphate groups,
stronger the binding, but a very limited specificity due to the 2-phosphate was also observed. On the other hand, the PH
domains from RAC-protein kinase and diacylglycerol kinase specifically bound inositol 1,3,4,5,6-pentakisphosphate and
inositol 1,4,5,6-tetrakisphosphate most strongly. The PH domain from the 130 kDa protein, however, had a preference for
inositol 1,4,5-trisphosphate and 1,4,5,6-tetrakisphosphate. Comparison was also made between binding of inositol 1,4,5-tri-
sphosphate, inositol 1,3,4,5-tetrakisphosphate and soluble derivatives of their corresponding phospholipids. The PH domains
examined, except that from pleckstrin, showed a 8- to 42-times higher affinity for inositol 1,4,5-trisphosphate than that for
corresponding phosphoinositide derivative. However, all PH domains had similar affinity for inositol 1,3,4,5-tetrakisphos-
phate compared to the corresponding lipid derivative. The present study supports our previous proposal that inositol
phosphates andror inositol lipids could be important ligands for the PH domain, and therefore inositol phosphatesrinositol
Abbreviations: SH domain, src homology domain; PH domain, pleckstrin homology domain; PLC, phospholipase C; Btk, Bruton
 .tyrosine kinase; GST, glutathione S-transferase; GroPIns 4,5 P , glycerophosphoryl-D-myo-inositol 4,5-bisphosphate; RAC-PK, RAC2
 .protein kinase; PtdIns 4,5 P , phosphatidylinositol 4,5-bisphosphate; DGK, diacylglycerol kinase; p130, the protein with molecular mass2
of 130 kDa; PleNPH, N-terminal PH domain of pleckstrin; RACgPH, PH domain of RAC-PKg; DGKdPH, PH domain of DGK-d;
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lipids may have the considerable versatility in the control of diverse cellular function. Which of these potential ligands are
physiologically relevant would depend on the binding affinities and their cellular abundance. q 1997 Elsevier Science B.V.
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1. Introduction
It is now well-recognised that many of the proteins
which participate in cell signalling contain structural
modules involved in regulatory interactions between
components of signal transduction cascades. Many
 .studies have focused on src homology SH domains
revealing that most SH2 and SH3 domains function
as a phosphotyrosine binding and a proline-rich re-
w xgion binding modules, respectively 1 . On the other
 .hand, roles of the pleckstrin homology PH domain
originally described as ;120 amino acid region of
. w xsequence similarity are largely unknown 2,3 in
spite of the accumulation of the structural informa-
tion obtained from nuclear magnetic resonance
 . w xNMR and X-ray crystallography 4–11 . Therefore,
current efforts to determine the ligand-binding char-
acteristics of the PH domains lie at the heart of the
search for their function and overall physiological
significance.
Studies of inositol phosphates and inositol lipids as
 .the PH domain ligands, focused on Ins 1,4,5 P and3
 . w xPtdIns 4,5 P 7,8,11–15 , molecules with well estab-2
w xlished role in intracellular signalling 16,17 . Studies
in this laboratory and those of Rebecchi and col-
leagues have demonstrated that phospholipase C-d1
 .PLC-d has high affinity and high specificity for1
both of these ligands before the term ‘‘PH domains’’
w xhad emerged 18–21 and that the binding site mapped
w xwithin the PH domain 22–24 . The crystal structure
of the PLC-d PH domain in a complex with1
 .Ins 1,4,5 P revealed that the recognition of3
 .  .Ins 1,4,5 P and the PtdIns 4,5 P head-group in-3 2
volves extensive interactions with the 4- and 5-phos-
phoryl groups and fewer interactions with the 1-phos-
w xphate 11 . A likely function of PLC-d PH domain1
 .binding to PtdIns 4,5 P is to provide an attachment2
to cellular membranes containing this phospholipid. It
w xhas also been suggested 11,18,24 that changes in
 .cellular concentrations of PtdIns 4,5 P and2
 .Ins 1,4,5 P could regulate membrane binding of3
PLC-d , and consequently its activity. The PH do-1
mains from several other proteins have been also
 .  .shown to bind PtdIns 4,5 P andror Ins 1,4,5 P2 3
w x7,8,11–15 but a physiological significance of the
binding remained obscure. For example, the PH do-
 .main of pleckstrin can bind PtdIns 4,5 P with some2
 .specificity but the soluble Ins 1,4,5 P head-group is3
only an effective competitor when present in a large
w xexcess 7 . In the case of the PH domain of spectrin,
 .  .the affinity for both PtdIns 4,5 P and Ins 1,4,5 P is2 3
 .rather weak Kd 40 mM and only the binding to the
more abundant lipid could be physiologically relevant
w x8 .
Further studies of potential ligands for the PH
domain revealed the inositol phosphates and inositol
 .  .lipids other than PtdIns 4,5 P and Ins 1,4,5 P could2 3
 .be involved. Studies of the 130 kDa protein p130
 .which has been isolated as an Ins 1,4,5 P binding3
w xprotein in this laboratory, together with PLC-d 181
have shown that, unlike PLC-d , the PH domain has1
 .the same affinity for Ins 1,4,5,6 P as that for4
 . w xIns 1,4,5 P 18,19,25,26 . This led us to propose that3
some of the PH domains derived from various pro-
teins may specifically bind different inositol phos-
w xphates 25,26 . Very recently, this proposal has been
w xsupported by work of Fukuda et al. 27 ; they re-
ported that the PH domain of Bruton tyrosine kinase
 .  .Btk specifically binds to Ins 1,3,4,5 P and that a4
point mutation found in human X-linked agamma-
globulinemia and murine X-linked immunodeficiency
abolished the binding, thus suggesting causal link to
w xthe illnesses. Furthermore, Salim et al. 28 reported
that the PH domain derived from dynamin and Btk
 .showed a distinct specific binding to PtdIns 4,5 P2
 .and PtdIns 3,4,5 P , respectively. Therefore, the pre-3
sent study is undertaken to examine whether the PH
domains from other proteins could specifically bind
different inositol phosphates and thus further evaluate
w xour proposal 25,26 .
Another important question regarding characterisa-
tion of the PH domain ligands arose from a compari-
son of the binding to inositol lipids with the binding
to inositol phosphates corresponding to their head-
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w xgroup. Harlan et al. 7 have reported that the PH
domain of spectrin has a much higher affinity for
 .PtdIns 4,5 P than for its soluble polar-head,2
 .Ins 1,4,5 P , indicating that glycerol andror fatty3
acid moiety is involved in a high-affinity binding.
This would be constant with the proposal of Ci-
w xfuentes et al. 21 that a specific binding of some PH
 .domains to PtdIns 4,5 P can act as a membrane2
w xtethering device. However, Gibson et al. 29 argued
against the idea pointing out that the PH domains
lack hydrophobic pocket sufficient for accepting the
fatty acid moieties of phospholipids. Furthermore, the
glycerolrfatty acid moieties could cause a sterical
hindrance in the binding process, resulting in much
higher affinity for the soluble inositol phosphate than
for its parent phospholipid. To further address this
issue, we compared the affinities between inositol
phosphates and the soluble derivatives of their parent
lipids for the binding to the PH domains selected for
this study.
2. Materials and methods
2.1. Materials
w3 x  . H Ins 1,4,5 P specific radioactivity:3
. w3 x  . 777GBqrmmol and H Ins 1,3,4,5 P specific ra-4
.dioactivity: 777GBqrmmol were purchased from
 .Du Pont-New England Nuclear Boston, MA . Inosi-
tol phosphates and soluble analogues of inositol lipids
used in this study were chemically synthesised as
w xdescribed previously 30–33 , except that L-
 .  .Ins 1,4,5 P and Ins 1,2,3,4,5,6 P were obtained from3 6
 .Sigma St. Louis, MO and used without further
purification. Ni-NTB-resin and pQE30 were from
 .Quiagen Chatsworth, CA and glutathione–Sep-
harose 4B and pGEX-4T series were from Pharmacia
 . Uppsala, Sweden . Thrombin was from Sigma St.
.Louis, MO . Other reagents were of the highest grade
available.
2.2. Plasmid construction
The PH domains of g-isozyme of RAC-protein
 .kinase RAC-PKg , d-isozyme of diacylglycerol ki-
 .nase DGK-d and the N-terminal PH domain of
pleckstrin were expressed as glutathione S-transferase
 .GST -fusion proteins using pGEX vectors. For the
expression of the PH domain of 130 kDa protein,
pQE30 His-tag vector was used. Construction of
plasmids encoding the PH domain from p130
 .  .p130PH and RAC-PKg RACgPH have been de-
w xscribed previously 26,34 . For the expression of the
 .N-terminal PH domain of pleckstrin PleNPH , the
cDNA encoding amino acid residues 2–102 was
w xgenerated by reverse transcriptase-PCR 35 . First-
strand cDNA template was synthesised from 0.1 mg
 .qof poly A RNA prepared from human Jurkat T-cells.
PCR was performed to amplify the selected cDNA
w xsequence of human pleckstrin 36 using the synthetic
oligonucleotide primers 5X-GCGGATCCGAAC-
C A A A G C G G A T C A G A G A -3 X a n d 5 X-
GCGGATCCGCCTCCTTCAATGCATTTAA-3X. To
facilitate subcloning, BamHI endonuclease sites un-
. Xderlined were added to the 5 -ends of both primers.
The amplified products were digested with BamHI
and subcloned into pGEX-2T vector. The nucleotide
sequence was confirmed by dideoxy chain-termina-
tion method.
The cDNA fragment encoding the PH domain
 .  .amino acid residues 8–107 of DGK-d DGKdPH
w xwas generated by PCR using clone DGKD103 35
and the synthetic primers 5X-GGAGATCTCAGAC-
C A T C A T C A A A G A G G G - 3 X a n d 5 X-
GGAGATCTCTCAAAGTGCTCCCTGTTCT-3X.
 . XBgl II sites underlined were added to the 5 -ends of
both primers. The reactions were carried out under
w xthe conditions described 37 . The resulting DNA
fragment was digested with Bgl II, subcloned into
pGEX-2T vector, and sequenced by dideoxy chain-
termination method.
2.3. Expression and purification of recombinant PH
domains
Expression of recombinant proteins was induced
 .with 1 mM isopropyl b-D-thiogalactoside IPTG
added to a bacterial culture grown at 378C until the
 .absorbance at 550 nm reached 0.5–0.6 about 5 h .
The culture supplemented with IPTG was incubated
at 258C for further 24 h. The change to 258C after
addition of IPTG resulted in larger amounts of solu-
ble GST-fusion proteins. In the case of the p130PH
with the His-tag there was no difference in the
amounts of soluble protein present in cultures grown
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at 378C for 5 h and those grown at 258C for 24 h.
After incubation, cells were collected by centrifuga-
tion and lysed by sonication in 0.1 M-NaCl and
 .10 mM Tris–HCl pH 7.5 buffer A for the GST-fu-
sion proteins or in 0.3 M-NaCl and 50 mM-phosphate
 .buffer pH 8.0 buffer B for the His-tagged protein.
Triton X-100 was added to the homogenates to a
 .final concentration of 1% vrv , followed by an
incubation at 48C for 30 min and subsequent clearing
by centrifuging at 15 000=g for 20 min. The result-
ing supernatants were applied to a 1 ml column,
containing either glutathione–Sepharose 4B in buffer
A or nitrilotriacetic acid resin in buffer B, and washed
with the buffers containing 0.5 M NaCl. For purifica-
tion of PleNPH, thrombin at a concentration of
1r100 of recombinant resin-bound protein, as esti-
mated by a SDS-polyacrylamide gel electrophoresis
.and a Coomassie Brilliant blue staining was added to
the column and incubation carried out at 258C for 1 h.
Subsequent elution separated the PH domain protein
from GST that remained bound to the column. In the
case of both RACgPH and DGKdPH, a solution of
10 mM-reduced glutathione and 50 mM-Tris–HCl pH
.8.0 was applied to the column to elute them as
GST-fusion proteins. A His-tagged p130PH was
eluted from a column of nitriotriacetic acid resin by a
solution of 0.3 M-imidazole. All PH domain prepara-
tions were subsequently dialyzed against 0.1 M-NaCl
 .and 10 mM-Tris–HCl pH 8.3 .
2.4. Binding assay
w3 x  .Binding of the PH domain to H Ins 1,4,5 P or3
w3 x  .H Ins 1,3,4,5 P was assayed as follows. The mix-4
 . w3 x  .ture 100 ml containing 6.0 nM- H Ins 1,4,5 P or3
w3 x  .  .H Ins 1,3,4,5 P 2.2 kBq radioactivity and a4
preparation of one of the PH domain proteins ;
.  .10 mg in 50 mM-Tris–HCl pH 8.3 , 1 mM-EDTA,
0.2%-Triton X-100, was incubated on ice for 15 min.
This was followed by addition of 50 ml of
10 mgrml-bovine g-globulin and 0.5 ml of 30%
 .wrv -polyethyleneglycol 6000. The precipitate
formed after centrifugation at 15 000 rpm for 5 min
was dissolved in 0.5 ml of 0.1 N-NaOH and then
counted for the radioactivity as an emulsion with 5 ml
of scintillation cocktail. Non-specific binding in the
 .presence of 100 mM Ins 1,4,5 P was also measured3
and subtracted from the values measured in its ab-
sence, allowing calculations of the specific binding.
3. Results and discussion
3.1. The PH domains from p130, RAC-PK, DGK and
pleckstrin
The PH domains selected for this study have been
derived from unrelated proteins with distinct cellular
functions. Although some ligand binding properties
of these PH domains have been reported, binding of
inositol phosphates and inositol lipids to the isolated
domains has not been addressed systematically or the
PH domains directly compared with each other.
PleNPH from pleckstrin, the first molecule where the
PH domain have been described, has been reported
 . w xnot to bind Ins 1,4,5 P 12,13 . RACgPH from RAC3
 .protein kinase also known as Akt or PKB , impli-
cated in signalling downstream of PtdIns-3-kinase,
has been reported to bind inositol lipids but the
identity of the preferred ligand remain inconclusive;
w xJames et al. 38 reported that RAC-PK specifically
bound phosphatidylinositol 3,4,5-trisphosphate,
w xwhereas very recently Franke et al. 39 reported that
this enzyme distinctly bound to phosphatidylinositol
3,4-bisphosphate, but not to phosphatidylinositol
3,4,5-trisphosphate. DGKdPH has not been previ-
ously studied and was selected to examine whether it
shows a preference for inositol lipids present in the
plasma membrane where the substrate for DGK re-
sides. Binding properties of p130PH have been exam-
w xined using an intact p130 25,26 and a study of the
isolated domain allows comparison of its binding
specificity with the binding specificity of the whole
molecule. Fig. 1 shows the sequence alignments and
Coomassie Blue stained SDS-polyacrylamide gel of
the PH domains of proteins used in the present study.
Purities of these proteins were 93.3"8.2%, 80.3"
7.8%, 86.7"7.9% and 69.7"7.5% for p130PH,
PleNPH, RACgPH and DGKdPH, respectively, as
assessed by the Coomassie Blue-staining, followed
by a densitometric scan analysis.
Sequence alignment in Fig. 1 also includes PLC-d1
 .whose crystal structure in a complex with Ins 1,4,5 P3
w xwas analyzed 11 . The alignment is based on sec-
ondary structure elements from known three-dimen-
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sional structures of pleckstrin, b-spectrin, dynamin
and PLC-d . A conserved polypeptide fold two or-1
thogonal anti-parallel b-sheets composed of three and
four strands with a single a-helix that caps one end
w x.of the b-barrel 4–11 in spite of a low over-all
sequence similarity, allows prediction that the PH
domains used in the present study form a similar
three-dimensional structures. However, the ability to
 .bind inositol phosphate s cannot be predicted only
from their sequence alignments. Comparison of the
 .PH domainrIns 1,4,5 P complexes obtained for the3
w x w xPH domains from spectrin 8 , PLC-d 11 and dy-1
w xnamin 15 did not reveal a conserved set of residues
that coordinate the ligand.
3.2. Binding of inositol phosphate
PleNPH was first analyzed for binding of
 .  .Ins 1,4,5 P and Ins 1,3,4,5 P . As shown in Fig.3 4
 . w3 x  .2 a , H Ins 1,4,5 P bound to PleNPH was dis-3
 .placed by unlabelled Ins 1,4,5 P in a dose-dependent3
 .manner. However, Ins 1,3,4,5 P was more potent in4
 .  .  .Fig. 1. Sequence alignments A and SDS-polyacrylamide gel electrophoresis B of the PH domains used in the present study. A
Sequence alignments also include the PH domain of PLC-d . The underlined sequence represents that proposed to be essential for1
 . w xIns 1,4,5 P binding 22,23 . Boxed amino acids represent those verified to interact with the PH domain by X-ray crystallographic3
w x  .analysis 11 . B p130PH, PleNPH, RACgPH and DGKdPH were applied to each lane from the left. The latter two samples were further
analyzed as fusion protein with GST.
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 . w3 x  .Fig. 2. A Displacement of H Ins 1,4,5 P bound to PleNPH by3
 .  .  .Ins 1,4,5 P and Ins 1,3,4,5 P . Isolated PleNPH ;10 mg was3 4
w3 x  .assayed for binding at 6.0 nM of H Ins 1,4,5 P in the presence3
 .of various concentrations of unlabelled Ins 1,4,5 P or3
 .Ins 1,3,4,5 P . Non-specific binding in the presence of 1 mM4
 .Ins 1,4,5 P was assayed and subtracted from that in its absence3
to determine the specific binding. Each point represents the
mean"SE of four determinations. Following results were simi-
larly obtained, unless otherwise stated. Inset represents the
 . w3 x  .Scatchard analysis. B Displacement of H Ins 1,3,4,5 P bound4
 .  .to PleNPH by Ins 1,4,5 P and Ins 1,3,4,5 P . Experimental con-3 4
 .ditions were the same as those in A , except that
w3 x  . w3 x  .H Ins 1,3,4,5 P was used in place of H Ins 1,4,5 P .4 3
 .  .  .  .Ins 1,4,5 P v , Ins 1,3,4,5 P B .3 4
the displacement, indicating that this inositol tetrakis-
 .phosphate has higher affinity than Ins 1,4,5 P . To3
w3 x  .confirm this observation, H Ins 1,3,4,5 P was used4
w3 x  .in the binding assay instead of H Ins 1,4,5 P . Fig.3
 .2 b show s the displacem ent of bound
w3 x  .  .H Ins 1,3,4,5 P by unlabelled Ins 1,4,5 P and4 3
 .  .Ins 1,3,4,5 P and demonstrates that the Ins 1,3,4,5 P4 4
was more potent, as seen in the experiments using
w3 x  .H Ins 1,4,5 P . Scatchard analyses of the data,3
shown in the inset of each figure, revealed K valuesd
 .of 0.92"0.1 mM and 4.25"1 mM for Ins 1,3,4,5 P4
 .and Ins 1,4,5 P , respectively. B values calculated3 max
for these two ligands were similar. These results
 .provide direct evidence that Ins 1,4,5 P and3
 .Ins 1,3,4,5 P competitively bind to the same site in4
the PH domain and support use of the displacement
with unlabelled ligands as a valid assay to determine
order of affinities for different inositol phosphates.
Thus, the following experiments were performed with
w3 x  .a combination of H Ins 1,4,5 P and unlabelled in-3
ositol phosphates.
w3 x  .Displacements of H Ins 1,4,5 P bound to3
PleNPH, RACgPH, DGKdPH and p130PH by sev-
eral inositol phosphates are shown in Fig. 3, Fig. 4,
Fig. 5 and Fig. 6, respectively. The results using a
wider range of inositol phosphates with the IC50
values are shown in Table 1. In the case of PleNPH
 .  .Fig. 3 and Table 1 , L-Ins 1,4,5 P was as effica-3
cious as its D-enantiomer, and the regioisomer
 .Ins 1,3,4 P had a similar potency. All InsP regioi-3 4
w  .  .somers examined Ins 1,3,4,5 P , Ins 1,4,5,6 P and4 4
 . xIns 3,4,5,6 P , despite of different dispositions of4
phosphates on the inositol ring, were to a similar
degree more potent than InsP series while3
 .Ins 1,3,4,5,6 P was even more potent than InsP5 4
series. Together these data suggest non specific bind-
ing of inositol phosphates. However, a phospho-
serine, a soluble analogue of anionic phospholipid
 .phosphatidylserine at up to 100 mM did not show
any inhibition of the binding. A very limited speci-
ficity, however, could be due to a sterical constraint
caused by the presence of the 2-phosphate since
 .  .Ins 1,2,4,5,6 P and Ins 1,2,3,4,5,6 P were about 5-5 6
 .times less potent than Ins 1,3,4,5,6 P . In the case of5
 .  .RACgPH Fig. 4 and Table 1 , Ins 1,4,5,6 P and4
 .Ins 1,3,4,5,6 P were most efficacious at displacing5
w3 x  .  .H Ins 1,4,5 P , closely followed by Ins 1,4,5 P and3 3
InsP . There was a clear difference in the efficiency6
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w3 x  .Fig. 3. Displacement of H Ins 1,4,5 P bound to PleNPH by3
selected inositol phosphates and inositol lipid derivatives.
 .  .  .  .  .  .Ins 1,4,5 P v , Ins 1,3,4,5 P B , Ins 1,3,4,5,6 P ’ ,3 4 5
 .  .  .  .GroPIns 4,5 P ‘ , DiBzGroPIns 3,4,5 P I .2 3
between the enantiomer and regioisomer of
 .Ins 1,4,5 P ; the same was observed for InsP and3 4
InsP . In all cases, dispositions of fourrfive phos-5
phates on the inositol ring made a clear difference in
the affinity suggesting that these residues contribute
towards specific binding of inositol phosphates by
 .  .RACgPH. Ins 1,4 P , a polar head of PtdIns 4 P and2
w3 x  .Fig. 4. Displacement of H Ins 1,4,5 P bound to RACgPH.3
 .  .  .  .  .Unlabelled Ins 1,4,5 P v , Ins 1,3,4,5 P B , Ins 1,4,5,6 P3 4 4
 .  .  .  .  .^ , Ins 1,3,4,5,6 P ’ , GroPIns 4,5 P ‘ and DiBz-5 2
 .  .GroPIns 3,4,5 P I were used for competition.3
w3 x  .Fig. 5. Displacement of H Ins 1,4,5 P bound to DGKdPH.3
 .  .  .  .  .  .Ins 1,4,5 P v , Ins 1,3,4,5 P B , Ins 1,4,5,6 P ^ ,3 4 4
 .  .  .  .  .Ins 1,3,4,5,6 P ’ , GroPIns 4,5 P ‘ , DiBzGroPIns 3,4,5 P5 2 3
 .I .
 . w3 x  .Ins 4,5 P displaced H Ins 1,4,5 P bound to2 3
RACgPH at more than 100 mM and 80 mM, respec-
 .tively results not shown . DGKdPH had the highest
 .  .affinity for Ins 1,3,4,5,6 P followed by Ins 1,4,5,6 P5 4
 .Fig. 5 and Table 1 . Stereospecific and regioisomer
specific binding among a series of InsP , InsP and3 4
w3 x  .Fig. 6. Displacement of H Ins 1,4,5 P bound to p130PH.3
 .  .  .  .  .  .Ins 1,4,5 P v , Ins 1,3,4,5 P B , Ins 1,4,5,6 P ^ ,3 4 4
 .  .  .  .  .Ins 1,3,4,5,6 P ’ , GroPIns 4,5 P ‘ , DiBzGroPIns 3,4,5 P5 2 3
 .I . Each point represents the mean of two determinations.
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Table 1
w3 x  .Summary of data: IC values of inositol phosphates in the displacement of H Ins 1,4,5 P50 3
PleNPH RACgPH DGKdPH p130PH
 .  .  .  .mM mM mM mM
a .  .  .  .  .Ins 1,4,5 P 3.6 12 0.06 1.7 0.06 5 5.6 13
 .  .  .  .  .L-Ins 1,4,5 P 3.6 12 0.4 11 0.15 12 250 453
 .  .  .  .  .Ins 1,3,4 P 4.5 15 0.6 17 0.16 13 )1000 )1803
 .  .  .  .  .Ins 1,3,4,5 P 1.0 3.3 0.3 8.3 0.035 2.9 30 5.44
 .  .  .  .  .Ins 1,4,5,6 P 1.2 4 0.036 1 0.02 1.7 6.0 1.14
b .  .  .  .Ins 3,4,5,6 P 1.2 4 0.14 3.9 0.034 2.8 nd4
 .  .  .  .  .Ins 1,3,4,5,6 P 0.3 1 0.036 1 0.012 1 36 6.45
 .  .  .  .Ins 1,2,4,5,6 P 1.6 5.3 0.14 3.9 0.06 5 nd5
 .  .  .  .  .Ins 1,2,3,4,5,6 P 1.8 6 0.06 1.7 0.055 4.6 38 6.86
 .  .  .  .  .Gro P Ins 4,5 P 7.0 23 2.5 69 0.6 50 45 82
 .  .  .  .  .DiBzGro P Ins 3,4,5 P 1.1 3.7 0.45 12 0.05 4.2 22 3.93
 .Gro P Ins 4,5 P2
c .  .  .  .  .rIns 1,4,5 P 7.0r3.9 1.9 2.5r0.06 42 0.6r0.06 10 45r5.6 83
 .DiBzGro P Ins 3,4,5 P3
 .  .  .  .  .rIns 1,3,4,5 P 1.1r1.0 1.1 0.45r0.3 1.5 0.05r0.035 1.4 22r30 0.74
a Number in parentheses of upper part of the Table represents the value of IC relative to that seen for inositol phosphate which was the50
most potent.
b Not done.
c Number in parentheses of lower part of the Table represents the ratio.
InsP were observed. However, they were less pro-5
 .nounced than observed with RACgPH. Ins 1,4 P , a2
 .  .polar head of PtdIns 4 P and Ins 4,5 P displaced2
w3 x  .H Ins 1,4,5 P bound to DGKdPH at 60 mM and3
 .25mM, respectively results not shown . Most strik-
ing differences in the affinity among stereo- and
regio-isomers of InsP were observed with p130PH,3
 .as shown in Fig. 6 and Table 1. L-Ins 1,4,5 P or3
 .Ins 1,3,4 P was 31-fold or )100-fold weaker than3
 .  .Ins 1,4,5 P , respectively. Ins 1,4,5,6 P was as po-3 4
 . w3 x  .tent as Ins 1,4,5 P at displacing H Ins 1,4,5 P .3 3
The specificity observed is consistent with the data
obtained using a w hole m olecule and
w3 x  . w xH Ins 1,4,5,6 P prepared ourselves 26 .4
Direct comparison of four different PH domains
described above have shown that although they all
could bind inositol phosphates, degree of specificity
and identity of the preferred ligand varies. PleNPH
demonstrated only very limited specificity and it
mainly bound inositol phosphates according to a
number of phosphates on the inositol ring, i.e. more
phosphate groups, stronger the binding. Thus, the
negative charges of tris-, tetrakis- or pentakis-phos-
phates on the inositol ring appear to provide interac-
tions for the bonding, indicating that the binding is
simply due to electrostatic interactions between nega-
tive charges of the phosphates and positive charges of
basic amino acids. In contrast, RACgPH and
 .DGKdPH preferentially bound Ins 1,3,4,5,6 P and5
 .to a slightly lesser extent Ins 1,4,5,6 P , whereas4
 .p130PH had an equal preference for Ins 1,4,5 P and3
 .Ins 1,4,5,6 P . These three types of PH domains ex-4
hibited a clear discrimination in the recognition among
regioisomers and enantiomer of InsP , InsP and InsP .3 4 5
Analysis of these PH domains also provided insight
into major determinants of their specificity. As with
wother PH domains characterised to date 2,7,8,12–
x15,26 , the 4,5-vicinal phosphate pair was an essen-
tial determinant of ligand specificity while the 1-
phosphate increased the affinity. This conclusion is
supported by the findings that among inositol-bi-
 .sphosphates only Ins 4,5 P was recognised and2
 .  .Ins 1,4,5 P was much more potent than Ins 4,5 P .3 2
Disposition of the 3-phosphate positively contributes
to the recognition only by DGKdPH, probably by
providing arms for salt-bridge formations. As shown
 .in Fig. 5 and Table 1, Ins 1,3,4,5 P was a slightly4
 .stronger ligand than Ins 1,4,5 P and in a similar way3
 .  .Ins 1,3,4,5,6 P was more potent than Ins 1,4,5,6 P .5 4
Unlike DGKdPH, in cases of RACgPH and p130PH
the 3-phosphate appears to provide a structural con-
straint. This is illustrated by weaker binding of
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 .  .Ins 1,3,4,5 P in comparison with Ins 1,4,5 . Obser-4 3
 .vation that Ins 1,3,4,5,6 P was as potent as5
 .Ins 1,4,5,6 P could be explained by compensation of4
the 3-phosphate charge with the 6-phosphate. Pres-
ence of the 6-phosphate seemed to be important in
cases of RACgPH and DGKdPH since it was found
 .  .that Ins 1,4,5,6 P or Ins 1,3,4,5,6 P was more po-4 5
 .  .tent than Ins 1,4,5 P or Ins 1,3,4,5 P , respectively.3 4
Binding to p130PH, however, does not seem to be
 .influenced by the 6-phosphate since Ins 1,4,5 P and3
 .  .Ins 1,4,5,6 P as well as Ins 1,3,4,5 P and4 4
 .Ins 1,3,4,5,6 P bound to p130PH with equal affinity.5
Disposition of the 2-phosphate seems to provide a
steric hindrance for inositol phosphate binding to
RACgPH, DGKdPH and PleNPH but has a little
effect on binding to p130PH as observed with a
whole molecule.
All these results suggest that even if the over-all
three-dimensional structures of the PH domains are
w xconserved 4–11 , precise structures of the pockets
for accommodating inositol phosphates are different.
Both, steric constraints that exclude additional phos-
 .phates and presence of basic amino acid s interact-
ing with their negative charges could contribute to-
wards the binding specificity observed.
3.3. Binding of inositol lipid deri˝ati˝es
To compare the affinity between inositol lipids and
their polar heads, we used soluble derivatives of
 .  .  .PtdIns 4,5 P and PtdIns 3,4,5 P , GroPIns 4,5 P2 3 2
 .and DiBzGroPIns 3,4,5 P , respectively; this allowed3
correct determination of inositol lipid concentrations
that is otherwise influenced by micelle formation.
However this also limited the difference to presence
of only glycerol moiety without lipid side-chains. In
 .the case of PleNPH, both GroPIns 4,5 P and DiBz-2
 .GroPIns 3,4,5 P had almost the same efficiency in3
the displacement as their respective polar head moi-
eties, inositol tris- and tetrakis-phosphates Table 1,
.bottom part . Thus, the glycerol moieties does not
seem to impose a sterical constraint for the interac-
tion and therefore inositol lipids could have the same
affinity as corresponding inositol phosphate for bind-
 .ing to PleNPH. In other three cases Table 1 , DiBz-
 .  .GroPIns 3,4,5 P had similar affinity as Ins 1,3,4,5 P3 4
 .  .while GroPIns 4,5 P was weaker than Ins 1,4,5 P2 3
by 8- to 42-fold. This difference could be caused by
either a steric hindrance due to the glycerol moiety
andror requirement for the fully ionized 1-phos-
phate. An explanation why such difference is not
 .seen betw een D iBzG roPIns 3,4,5 P and3
 .Ins 1,3,4,5 P could be that the absence of the 1-4
phosphate may be compensated by interactions of the
3-phosphate with the PH domains.
3.4. Ligand binding properties of the PH domains
and their physiological significance
Together with specificity, determination of the PH
domain affinities for their inositol phosphaterinositol
lipid ligands provides a basis for consideration of
their interactions in vivo. The IC values the lowest50
was about 6 mM for p130PH, while those for PleNPH,
RACgPH and DGKdPH were 0.3 mM, 0.036 mM
.and 0.012 mM, respectively were within micromolar
and submicromolar range. Surprisingly, the lowest
affinity was determined for highly specific p130PH
and in comparison with the intact protein this was a
substantial reduction. It is likely that folding and
stability of the PH domain may be affected when
expressed in isolation rather than as a part of the
multidomain protein. Therefore, affinities measured
for isolated PH domains could be lower than their
affinities in the context of an intact protein. However,
as described above, this did not influence changes in
the specificity.
The determination of physiologically relevant lig-
ands depends not just on relative binding affinities,
but also on relative intracellular abundance of a
ligand. Although free concentrations of inositol lipids
are difficult to evaluate, measurements of their total
intracellular concentrations have been reported. Total
 .  .cellular levels of PtdIns 4,5 P and PtdIns 3,4,5 P2 3
have been estimated to be 30–160 mM and less than
w x0.1 mM, respectively 40,41 but the local concentra-
tions are likely to be higher. The concentrations of
 .PtdIns 4,5 P at the inner leaflet of neutrophils were2
estimated to be 5 mM decreasing to 3.5 mM upon
w xchemotactic peptide-stimulation see Ref. 41 . The
 .local concentrations of PtdIns 3,4,5 P seem to be3
much lower, 5mM in resting cells and 200 mM after
w xstimulation 41 . These estimates suggest that in order
 .to specifically recognise PtdIns 3,4,5 P , affinity for3
this ligand should be considerably higher than for
 .PtdIns 4,5 P . This has not been observed for any of2
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the PH domains tested with their soluble analogues or
headgroups.
Abundance of different inositol phosphates also
 .vary 1–100 mM and is influenced further by agonist
stimulation and differences in half-life. For example,
type 1-inositol 5-phosphatase acting on
 .  .Ins 1,4,5 P rIns 1,3,4,5 P is so active that their3 4
half-lives are within 10 sec, whereas those of
 .  .Ins 1,3,4 P rIns 1,3,4,6 P , whose concentration in-3 4
creases from 1–4 mM to 10–60 mM upon cell-stimu-
w xlation, is about 10 min 42 . Nonetheless, the PH
domains of pleckstrin, RAC-PK and DGK showed
 .preference and high affinity for Ins 1,3,4,5,6 P , and5
  . .this inositol phosphate as well as Ins 1,2,3,4,5,6 P6
is assumed to be most abundant in cells estimated to
w x .be 15–100 mM, see Ref. 17 for a review . Function
of this binding could be to inhibit interactions of the
PH domains with inositol lipids, affecting its cellular
localisation, or to influence protein function directly
by changing activity of the protein.
A role of inositol phosphates in determining sub-
cellular localisation by competing with binding to
membrane inositol lipids has been previously dis-
w xcussed for PLC-d PH domain 2,18,24 . Based on1
estimates of total inner-leaflet concentrations of Pt-
 .dIns 4,5 P it is possible that concentrations of free2
 .PtdIns 4,5 P , available for interactions with proteins,2
 .are also significantly higher than of Ins 1,4,5 P or3
other inositol phosphates. In this case, ability to
compete could result from higher affinity for inositol
phosphates. Indeed, we observed that the PH domain
of PLC-d had about 20-fold higher affinity for1
 .  .Ins 1,4,5 P than for PtdIns 4,5 P .3 2
There is also some evidence that binding of inosi-
tol lipidsrinositol phosphates may not be only impli-
cated in regulation of membrane attachment but could
also directly influence function of a PH domain
containing protein. For example, binding of
 .PtdIns 4,5 P to dynamin results in changes of its2
w x w xGTP-ase activity 15,28 . In case of RAC-PK 39 ,
kinase activity of this protein is stimulated in the
presence of the PH-domain ligand.
3.5. Conclusion
Four types of the PH domain examined here were
capable of binding inositol phosphates. However,
degree of specificity and identity of the preferred
ligand varied. The PH domains of RAC-PKg and
 .DGK-d bound Ins 1,3,4,5,6 P better than5
 .Ins 1,4,5,6 P which was also a good ligand. The PH4
 .domain of p130 had equal preference for Ins 1,4,5 P3
 .and Ins 1,4,5,6 P . Together with the reports that the4
PH dom ain of Btk preferentially binds
 .  . w xIns 1,3,4,5 P rPtdIns 3,4,5 P 27,28 , that PLC-d4 3 1
 . w xhas specificity for Ins 1,4,5 P 12,21–23 and that3
RAC-PK activity can be specifically stimulated by
 .PtdIns 3,4 P , the present study confirms our previ-2
ous proposal that the most likely ligand for the PH
domain is a specific inositol phosphate or correspond-
ing inositol lipid. The determination which of the
inositol lipids or inositol phosphates is a physio-
logically relevant ligand, would depend on the affin-
ity, the cellular abundance and the life time of these
inositol compounds in vivo. In the case of proteins
bearing the PH domains whose affinity to an inositol
phosphate is higher than that to its corresponding
inositol lipid, even if more abundant, the inositol
phosphate could have a regulatory role. An increase
upon cellular stimulation could be a negative regula-
tor of the protein binding to phosphoinositides via the
PH domain providing it is required for its function, as
w xproposed for PLC-d 24,43,44 . The ligand binding1
could also influence protein function directly
w x15,28,39 .
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